- Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment(2022)
Auteurs: Máté Kiss, Els Lebegge, Aleksandar Murgaski, Helena Van Damme, Daliya Kancheva, Jan Brughmans, Isabelle Scheyltjens, Ali Talebi, Robin Maximilian Awad, Yvon Elkrim, et al.
- Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages(2022)
Auteurs: Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeerk, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana Arnouk, Ahmed E. I. Hamouda, et al.
Pagina's: 3785-3801
- Understanding the effect and mechanisms of CD40 agonist therapy on tumour growth and dendritic cell vaccination strategies(2022)
Auteurs: Aleksandar Murgaski, Damya Laoui, Jo Van Ginderachter
Aantal pagina's: 179
- Macrophages are metabolically heterogeneous within the tumor microenvironment(2021)
Auteurs: Xenia Geeraerts, Juan Fernández-Garcia, Felix J. Hartmann, Kyra E. de Goede, Liesbet Martens, Yvon Elkrim, Ayla Debraekeleer, Benoit Stijlemans, Anke Vandekeere, Gianmarco Rinaldi, et al.
Pagina's: 110171
- Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors(2019)
Auteurs: Evangelia Bolli, Matthias D'Huyvetter, Aleksandar Murgaski, Danielle Berus, Geert Stangé, Emile J Clappaert, Sana Arnouk, Ana Rita Pombo Antunes, Ahmet Krasniqi, Tony Lahoutte, et al.
Pagina's: 1-11
- Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A's(2019)
Auteurs: Aleksandar Murgaski, Pauline M R Bardet, Sana Arnouk, Emile J Clappaert, Damya Laoui
- Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy(2018)
Auteurs: Emile J Clappaert, Aleksandar Murgaski, Helena Van Damme, Máté Kiss, Damya Laoui